Skip to content Skip to footer

Research Portal of the TU Dresden

Response to (K)RAS^G12C and EGFR Inhibition in a Patient With NRAS^G12C-Mutated Rectal Cancer

Research output: Contribution to journal › Case report › Contributed › peer-review

Contributors

Lino Möhrmann - , National Center for Tumor Diseases Dresden, German Cancer Consortium (Partner: DKTK, DKFZ), Helmholtz-Zentrum Dresden-Rossendorf, German Cancer Research Center (DKFZ) (Author)
Ani Cuberi - , Institute and Polyclinic of Diagnostic and Interventional Radiology (Author)
Sascha Brückmann - , TUD Dresden University of Technology (Author)
Sebastian Stasik - , Department of Internal Medicine I (Author)
Lukas C. Heukamp - , Institute for Hematopathology Hamburg GmbH (Author)
Martin Bornhäuser - , University Cancer Centre Dresden, Department of Internal Medicine I, National Center for Tumor Diseases Dresden (Author)
Hanno Glimm - , Department of Internal Medicine I, National Center for Tumor Diseases Dresden, German Cancer Consortium (Partner: DKTK, DKFZ), Helmholtz-Zentrum Dresden-Rossendorf, German Cancer Research Center (DKFZ) (Author)
Gunnar Folprecht - , Department of Internal Medicine I, University Cancer Centre Dresden (Author)

Details

Original language	English
Article number	e2200666
Journal	JCO precision oncology
Volume	7
Issue number	7
Publication status	Published - May 2023
Peer-reviewed	Yes

External IDs

PubMed	37262393
Mendeley	c79dee44-02a5-32ab-80a6-b8b571c35d3f
unpaywall	10.1200/po.22.00666

Keywords

Sustainable Development Goals

SDG 3 - Good Health and Well-being

Keywords

Humans, Mutation, Rectal Neoplasms/drug therapy, ErbB Receptors/genetics, Membrane Proteins, GTP Phosphohydrolases/genetics